Models Name |
Cat.No. |
Animal Type |
Disease Area |
Breast cancer (adenocarcinoma), xenograft (MCF7)/hypoxia-induced, in nude mouse (Balb/c)
|
AB44025 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDA-MB-231-TXSA (bone-metastatic)), in nude mouse (Balb/c)
|
AB44026 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (drug-resistant)), in athymic nude mouse (Balb/c)
|
AB44027 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (FGF18-knockdown)), in nude mouse (Balb/c)
|
AB44028 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (FGF18-overexpressing)), in nude mouse (Balb/c)
|
AB44029 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (Fra2-overexpressing)), in SCID mouse (Balb/c)
|
AB44030 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (HER2 [ERBB2]-overexpressing)), in athymic nude mouse (Balb/c)
|
AB44031 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (hMAGEA2-overexpressing)), in nude mouse (Balb/c)
|
AB44032 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (KDM3B-ETF1-overexpressing)), in nude mouse (Balb/c)
|
AB44033 |
mouse |
Cancer,breast (adenocarcinoma) |
Breast cancer (adenocarcinoma), xenograft (MDAMB231 (lapatinib-treated)), in athymic nude mouse (Balb/c)
|
AB44034 |
mouse |
Cancer,breast (adenocarcinoma) |